Floatz logo

Paliperidone

Iatrogenic Disease

Consorcio Centro de Investigación Biomédica en Red (CIBER)Small moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Iatrogenic Disease cohort.

View all 36

Same molecule, other indications

Paliperidone is also rated in:

schizoaffective disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
psychotic disorderActive
BBB
Indicative · Phase 4
76 / 100
View asset →
schizophreniaActive
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →